Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
Status:
Withdrawn
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The overall aim is to conduct a human physiologic study to assess the renal and neurohumoral
effects of CD-NP vs placebo in older subjects with stable chronic systolic heart failure and
moderate renal dysfunction.